Table 1

Multivariable models predicting willingness to receive COVID-19 vaccination and other SARS-CoV-2 and/or vaccine-related outcomes in patients with RMDs and healthy controls

Domain 1
Willingness to receive COVID-19 vaccination
Domain 2
Perceive oneself at risk of becoming infected with SARS-CoV-2
Domain 3
Perceive oneself at risk of developing severe COVID-19
Domain 4
Fear of COVID-19
vaccine-related AEs
OR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P value
Patients
 Rheumatologic Patients 0.24 (0.17 to 0.34)<0.0001 11.3 (8.0 to 15.9)<0.0001 11.06 (7.8 to 15.6)<0.00010.95 (0.52 to 1.7)0.865
 Healthy controlsRef.Ref.Ref.Ref.
Age1.01 (1.00 to 1.02)<0.0011.04 (1.03 to 1.05)<0.00011.04 (1.03 to 1.06)<0.00011.00 (0.98 to 1.02)0.880
Sex
 Female0.67 (0.47 to 0.95)<0.011.74 (1.18 to 2.56)<0.0011.61 (1.1 to 2.36)<0.12.25 (1.04 to 4.86)0.039
 MaleRef.Ref.Ref.Ref.
Domain 5
Distrust of COVID-19
vaccine
Domain 6
Willingness to reconsider decision pending more information
Domain 7
Influenza vaccination received in 2020
Domain 8
Pneumococcal vaccination received in 2020
OR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P value
Patients
 Rheumatologic Patients1.29 (0.20 to 8.15)0.781 3.08 (2.19 to 4.34)<0.0001 1.60 (1.18 to 2.16)0.002 2.23 (1.34 to 3.73)0.002
 Healthy controlsRef.Ref.Ref.Ref.
Age0.99 (0.94 to 1.05)0.9300.99 (0.98 to 1.00)0.2501.05 (1.04 to 1.06)<0.00011.06 (1.04 to 1.08)<0.0001
Sex
 Female0.30 (0.05 to 1.57)0.1551.37 (0.96 to 1.95)0.0781.04 (0.75 to 1.45)0.7780.89 (0.56 to 1.41)0.630
 MaleRef.Ref.Ref.Ref.
  • AEs, adverse events; RMD, rheumatic and musculoskeletal disease.